Oncoscience

Volume 2: Issue 10

pp777-999

Issue 10

About the Cover

The cover for the issue of Oncoscience features Figure 2C (“New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia”) from Panuzzo et al.

Editorials

Molecular network of HCC aggressiveness

https://doi.org/10.18632/oncoscience.194

Sang Geon Kim, Mi Jeong Heo, Yoon Mee Yang

p 777-778

PDF |  How to Cite

Actionability and precision oncology

https://doi.org/10.18632/oncoscience.236

Maria  Schwaederle, Razelle  Kurzrock

p 779-780

PDF |  How to Cite

Calcineurin/CXCR4 in T-ALL

https://doi.org/10.18632/oncoscience.238

Diana  Passaro, Christine Tran Quang, Jacques  Ghysdael

p 781-782

PDF |  How to Cite

The epigenetic regulator CTCF modulates BCL6 in lymphoma

https://doi.org/10.18632/oncoscience.239

Ana  Batlle-López, María G. Cortiguera, M. Dolores  Delgado

p 783-784

PDF |  How to Cite

MTH1 counteracts oncogenic oxidative stress

https://doi.org/10.18632/oncoscience.240

Dominick  G.A. Burton, Priyamvada  Rai

p 785-786

PDF |  How to Cite

IL13Rα2 signaling in colorectal cancer

https://doi.org/10.18632/oncoscience.241

Rubén A.  Bartolomé, J. Ignacio  Casal

p 787-788

PDF |  How to Cite

RUNX3 methylation and anti-tumor immunity

https://doi.org/10.18632/oncoscience.242

Trevelyan R. Menheniott, Louise M. Judd, Andrew  S. Giraud

p 789-790

PDF |  How to Cite

Cell polarity as a tumor suppressive mechanism

https://doi.org/10.18632/oncoscience.244

Maia  Al-Masri, Luke  McCaffrey

p 791-792

PDF |  How to Cite

Elafin: a double agent in breast and ovarian cancer

https://doi.org/10.18632/oncoscience.246

Yi  Feng, Kai  Doberstein, Ronny  Drapkin

p 793-794

PDF |  How to Cite

lnc RNAs, hypoxia and metastasis

https://doi.org/10.18632/oncoscience.247

Benilde  Jiménez, María  Tiana, Luis  del Peso

p 795-796

PDF |  How to Cite

Linking omentum and ovarian cancer: NO

https://doi.org/10.18632/oncoscience.248

Bahar Salimian Rizi, Deepak  Nagrath

p 797-798

PDF |  How to Cite

Targeting MUC4 in pancreatic cancer: miRNAs

https://doi.org/10.18632/oncoscience.249

Nicolas  Jonckheere, Fatima  Lahdaoui, Isabelle  Van Seuningen

p 799-800

PDF |  How to Cite

Food as a drug

https://doi.org/10.18632/oncoscience.250

Paul A. Spagnuolo, Michael A. Rogers

p 801-802

PDF |  How to Cite

Endogenous Dach1 in cancer

https://doi.org/10.18632/oncoscience.251

Kongming  Wu, Xun  Yuan, Richard  Pestell

p 803-804

PDF |  How to Cite

PEPCK in cancer cell starvation

https://doi.org/10.18632/oncoscience.252

Katharina  Leithner

p 805-806

PDF |  How to Cite

Synthetic lethality in KRas-driven cancer cells created by glutamine deprivation

Suman  Mukhopadhyay, Mahesh  Saqcena, David A. Foster

p 807-808

PDF |  How to Cite

Stem cell hunt in NHL

https://doi.org/10.18632/oncoscience.234

Olaf   Merkel, Lukas  Kenner, Suzanne D. Turner

p 809-810

PDF |  How to Cite

Akt-Girdin as oncotarget

https://doi.org/10.18632/oncoscience.233

Masahide  Takahashi, Naoya  Asai, Atsushi  Enomoto

p 811-812

PDF |  How to Cite

Targeting Bcl2 in cancer

https://doi.org/10.18632/oncoscience.232

Guo  Chen, Xingming  Deng

p 813-814

PDF |  How to Cite

Cell lines from circulating tumor cells

https://doi.org/10.18632/oncoscience.195

Klaus  Pantel, Catherine  Alix-Panabières

p 815-816

PDF |  How to Cite

Chemotherapy with ceramide in TNBC

https://doi.org/10.18632/oncoscience.196

Patrick  Legembre, Olivier  Micheau, Bruno  Segui

p 817-818

PDF |  How to Cite

Revisiting stroma in pancreatic cancer

https://doi.org/10.18632/oncoscience.198

Sheema  Khan, Meena  Jaggi, Subhash C. Chauhan

p 819-820

PDF |  How to Cite

Crumbs and Xpd in mitosis

https://doi.org/10.18632/oncoscience.199

Eunbyul  Yeom, Sung-Tae  Hong, Kwang-Wook  Choi

p 821-822

PDF |  How to Cite

ECO/siRNA nanoparticles and breast cancer metastasis

https://doi.org/10.18632/oncoscience.200

Zheng-Rong  Lu, William P. Schiemann

p 823-824

PDF |  How to Cite

MIR-491: CDKN2A tumor suppressor co-pilot

https://doi.org/10.18632/oncoscience.201

Lynette M. Moore, Wei  Zhang

p 825-826

PDF |  How to Cite

Molecular dissection of ependymomas

https://doi.org/10.18632/oncoscience.202

Kristian W. Pajtler, Stefan M. Pfister, Marcel  Kool

p 827-828

PDF |  How to Cite

Breast cancer regulated by fringe

https://doi.org/10.18632/oncoscience.203

Keli  Xu

p 829-830

PDF |  How to Cite

Post-transcriptional mapping reveals critical regulators of metastasis

https://doi.org/10.18632/oncoscience.207

George S. Hussey, Breege V. Howley, Philip H. Howe

p 831-832

PDF |  How to Cite

Chemosensitization strategies for the treatment of lung cancer

https://doi.org/10.18632/oncoscience.208

Laura  Senovilla, Guido  Kroemer

p 833-834

PDF |  How to Cite

CAF-specific markers: role of the TGFβ pathway

https://doi.org/10.18632/oncoscience.209

Susann  Busch, Göran  Landberg

p 835-836

PDF |  How to Cite

Heterogeneity of neuroblastoma

https://doi.org/10.18632/oncoscience.216

Elly Sau-Wai  Ngan

p 837-838

PDF |  How to Cite

FOXP3-microRNA-146-NF-κB as oncotarget

https://doi.org/10.18632/oncoscience.220

Deepa M. Etikala, Runhua  Liu, Lizhong  Wang

p 839-840

PDF |  How to Cite

EMT in immuno-resistance

https://doi.org/10.18632/oncoscience.226

Stéphane  Terry, Salem  Chouaib

p 841-842

PDF |  How to Cite

MiR-29/Hsp47 in ECM network

https://doi.org/10.18632/oncoscience.227

Ren  Xu

p 843-844

PDF |  How to Cite

Melanoma immunotherapy

https://doi.org/10.18632/oncoscience.228

Abhishek D. Garg, Aleksandra M. Dudek-Peric, Patrizia  Agostinis

p 845-846

PDF |  How to Cite

TACC3 in personalized medicine

https://doi.org/10.18632/oncoscience.229

Stephen  Murata, Loredana  Campo, Eun-Kyoung  Breuer

p 847-848

PDF |  How to Cite

Research Perspectives

Understanding why aspirin prevents cancer and why consuming very hot beverages and foods increases esophageal cancer risk. Controlling the division rates of stem cells is an important strategy to prevent cancer

https://doi.org/10.18632/oncoscience.257

Miguel  López-Lázaro

p 849-856

PDF |  Full Text |  How to Cite

Selective amino acid restriction therapy (SAART): a non- pharmacological strategy against all types of cancer cells

https://doi.org/10.18632/oncoscience.258

Miguel  López-Lázaro

p 857-866

PDF |  Full Text |  Supplementary Materials |  How to Cite

Conserved E2F mediated metastasis in mouse models of breast cancer and HER2 positive patients

https://doi.org/10.18632/oncoscience.259

Jonathan  Rennhack, Eran  Andrechek

p 867-871

PDF |  Full Text |  How to Cite

A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome

https://doi.org/10.18632/oncoscience.261

Walter  Arancio, Swonild Ilenia Genovese, Lucia  Bongiovanni, Claudio  Tripodo

p 872-879

PDF |  Full Text |  How to Cite

Research Papers

New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia

https://doi.org/10.18632/oncoscience.260

Cristina  Panuzzo, Gisella  Volpe, Elisa Cibrario Rocchietti, Claudia  Casnici, Katia  Crotta, Sabrina  Crivellaro, Giovanna  Carrà, Roberta  Lorenzatti, Barbara  Peracino, Davide  Torti, Alessandro  Morotti, Maria Pilar Camacho-Leal, Paola  Defilippi, Ornella  Marelli, Giuseppe  Saglio

p 880-891

Abstract |  PDF |  Full Text |  How to Cite